Category Archives: Platelet Rich Plasma Injections


Garrett Richards is the epitome of a risk-reward free agent – Bless You Boys

Free agent righthander Garrett Richards is one of the most successful what could have been stories of the past decade. Eye-popping stuff sabotaged by a lengthy injury history have made him a staple on lists of buy low candidates in fantasy baseball over the past few seasons. Yet despite it all, hes still put together a nice career thus far in the majors. The Detroit Tigers are in a situation where they can afford to place a small bet here, and Richards may offer more bang for your buck than any free agent out there.

Of course, theres a good reason why hes potentially available to a non-contender like the Tigers at this point in his career. While hed be a fascinating project to gift to new pitching coach Chris Fetter, Richards is something of a wild card at this point due to a mishandled elbow injury. Hes as likely to miss half the season as to give you 25 starts. Of course, you can pick up seemingly durable pitchers and get the same result, as the Al Avila led Tigers have proven repeatedly.

The odyssey of Garrett Richards elbow began in 2016. After three full seasons in the majors for the Los Angeles Angels, he was coming off a 2015 season in which he spun 207 13 quality innings and appeared to be coming into his own as a durable young starting pitcher who might be a tweak or two from stardom. Unfortunately, he suffered a partial tear to his UCL early in 2016 and missed most of the season. The solution would normally be Tommy John surgery, but Richards and the Angels, desperate to get back to the playoffs, elected instead to try platelet rich plasma injections. The hope was to use that treatment in combination with rehabilitation and get him back on the mound in 2017 rather than losing the whole season to surgery. This, like many decisions about pitchers the Angels have made in recent years, turned out terribly.

Richards ultimately made just six starts in 2017. He suffered a nerve issue in his biceps the first week of the season, and while imaging seemed to indicate that his UCL was undamaged, a string of related issues kept him off the field most of the season. Things seemed more promising in 2018. Richards came into the season apparently healthy, upped his breaking ball usage, and was posting the best strikeout rates of his career. It all came undone during a July 10th start against the Seattle Mariners. His UCL finally blew out and there was no other recourse than to finally undergo Tommy John surgery well over two years after the initial injury occurred.

Richards became a free agent after the 2018 season, and the San Diego Padres offered a two-year speculative deal hoping hed be fully healthy in time for them to cash in with him in 2020. Richards got back on the mound for a few innings late in the 2019 season, and miraculously his stuff was intact. He wasnt great for the Padres in 2020, but its par for the course to have some struggles returning from Tommy John surgery. What was encouraging was the fact that he was able to make 10 starts, stay healthy, and look pretty good at times. The Padres decided to put him in the bullpen in September in preparation for a super-reliever role in the postseason, but a 4.03 ERA, 4.28 FIP performance returning from Tommy John surgery is still fairly strong.

One of the wilder parts of this whole saga is that Richards has basically looked unchanged throughout. His fastball velocity has held up consistently despite the injury issues. His calling card, and the reason hes consistently of interest to pitching honks, is the elite spin rates he produces on his fastball, slider, and curveball, and those metrics have also remained elite throughout the injuries as well. His physical ability remains relatively undiminished.

Apart from the injury history, the one relative weakness for Richards has been the underwhelming movement on his fourseam fastball. In 2020, he averaged 95.1 mph, with a spin rate of 2626 rpms. Only 11 starters with 300 fastballs registered in Statcast this season threw harder. Only Trevor Bauer posted a higher average spin ratewhich is a story in itselfthan Richards did. Yet hes never managed anything like the kind of whiff rates produced by the Justin Verlanders and Max Scherzers of the power stuff set. Richards fastball spin is actually quite inefficient, as he checks in with well below average vertical and horizontal movement.

In an era when strikeouts rule, a fastball that doesnt generate many whiffs just isnt going to be highly valued, but in Richards case that can also be a little deceiving. His fastball does produce plenty of weak contact. Even in seasons when the average exit velocity of fastballs put into play spiked for him, he still gives up little power because his heavy, weird fourseamer is hard to lift with authority. Over the last four seasons combined, hitters have posted an ISO of just .155 and six total home runs against it. In some ways, Richards fastball is actually reminiscent of Spencer Turnbulls heater, another fourseamer with above average spin rate, but which somehow moves more like a power sinker.

Richards backs the fastball with a nasty pair of breaking balls. The slider is his main out pitch, checking in at 88.5 mph with a spin rate of 2893 rpms, premium spin rate for that class of pitch. Over the years hes really leaned into the slider and at this point he throws fastballs or sliders over 90 percent of the time. He does have a fairly monstrous curveball in his back pocket as well. He spins the curve in with an average of 3299 rpms, which is best in its class level spin rate as well. Each has well above average depth and Richards gets a lot of whiffs with each of them.

In recent years he hasnt commanded either pitch quite as well, leading to the occasional meatball, but overall his control has never been a problem. He doesnt issue that many free passes, but he hasnt always had consistent command and bite on his stuff either. The hope would be that with Richards now finally beyond his elbow issues, his old home run suppressing ways may return with sharper command.

This is actually a pretty good time for the Tigers to take a risk on an oft-injured but talented pitcher. His case is a bit of an extreme, but betting on pitchers returning to form in their second season following a return from Tommy John is a smart move, assuming said team isnt pinning their whole playoff hopes on it. Richards will still draw offers from contending teams, so it isnt a particularly likely fit, but if Al Avila could manage to add him to the rotation for 2021, suddenly the pitching staff has a chance to be pretty interesting. If things went well, theyd also have a pretty good trade chip.

Of course, the issue we havent addressed is fitting Richards into the rotation. MLB Trade Rumors projects a contract of two years, $16 million. That should easily be within range of the Tigers budget even assuming theyd like to add a veteran to both the outfield, the infield, and to address the catcher position. On a yearly AAV basis, Richards would cost roughly as much as Matt Boyd and Michael Fulmer would make in arbitration combined over the next two seasons. Of course he has more upside than either, and is less risky in terms of injuries than Fulmer.

On paper, the Tigers 2021 rotation is Spencer Turnbull, Matt Boyd, Michael Fulmer, Casey Mize, and Tarik Skubal, but apart from Turnbull there are questions marks with the whole group. And as we laid out a few weeks ago, even if all five current starters are healthy and perform relatively well, theyre still not going to provide the Tigers nearly enough innings to get through the season. Figuring out how to manage workloads is obviously now A.J. Hinch and Chris Fetters job, and theyre well aware the Tigers are going to need more pitching to avoid pushing their young prospects unwisely.

Theres been a lot of discussion among Tigers fans this offseason about what constitutes aggressive moves to get better versus simply spending on the top free agents. Sure, it could go wrong, but a minor two year investment doesnt constitute any real financial risk either. Richards is a pretty good example of a player who isnt particularly risky and has good upside. The Tigers will probably have to beat some other offers to land him, and they should.

Go here to read the rest:
Garrett Richards is the epitome of a risk-reward free agent - Bless You Boys

Las Vegas woman allegedly held ‘vampire facial’ parties while posing as nurse – New York Post

An unemployed Las Vegas woman posed as a nurse and gave unlicensed vampire facials to dozens of unwitting clients during illicit parties which left some patients with painful side effects or requiring medical attention, police said.

Maria Sabata Gutierrez, 49, was busted on Nov. 18 as officers executed a search warrant at her home, according to an arrest report obtained by the Las Vegas Review-Journal.

Gutierrez admitted to detectives to administering the treatment designed to re-inject platelet-rich plasma into the skin to activate collagen cells.

She also disclosed selling medications she purchases from Mexico to patients, an arrest report states. She is currently unemployed and does these medical procedures on the side.

Gutierrez, who is identified in the arrest report as Maria DeJesus Gutierrez, told detectives she had been doing the procedures for the past year on roughly 50-60 patients for about $100 a pop, police said.

An investigation was launched by detectives after a woman showed up at a Las Vegas hospital in late September with swelling and pain on her face and bumps in her mouth, police said.

The woman told investigators she got the trendy skin procedure after a recommendation from a friend who attended one of Gutierrezs vampire facial parties illicit get-togethers that took place every other week since as March or April, police said.

After Gutierrez took blood from the customers arms, it was then placed into a machine that separated it before being re-injected into her face, the woman told police.

The treatment at a licensed medical facility typically costs about $1,000, investigators said.

In addition to the vampire facials, [the customer] was also getting a similar procedure with her blood being reinjected into her buttocks, the arrest report states. This procedure has [been] happening weekly and cost $100.

While holding the parties, Gutierrez always wore medical scrubs and a backpack containing a blood centrifuge and other supplies. She told a witness she previously worked for a medical office and did the procedures regularly, but lost her license, police said.

Gutierrez also told a doctor who contacted her after one of her patients went to a hospital that she got her equipment online from Mexico, police said.

She then told the doctor she had been operating out of her trunk, according to the report.

The doctor told Gutierrez to stop performing vampire facials and got in touch with police, prompting undercover detectives to later set up a meeting with her and arranged to get the procedure for $212, police said.

Gutierrez, who is facing charges including furnishing a dangerous drug without a prescription and acting as a medical practitioner without a license, has a preliminary hearing set for March. Her attorney could not be reached for comment Tuesday, the newspaper reported.

Read the rest here:
Las Vegas woman allegedly held 'vampire facial' parties while posing as nurse - New York Post

PRP vs Corticosteroid Injections Which is the Ultimate Solution – Farmington, CT – Patch.com

This post was contributed by a community member. The views expressed here are the author's own.

PRP vs Corticosteroid Injections Which is the Ultimate Solution for Joint Pain?

Injury is a part of life, it is a lesson and reminder of our limits, but you dont have to let pain stop you from living the life you want. Joint damage and its resulting pain are some of the most common injuries attended to by doctors. For all of the different injuries that exist, the field of medicine is making strides towards newer and improved solutions for joint rejuvenation and eliminating pain. Up until today, most physicians have been utilizing cortisone injections (and their derivatives) to treat a wide variety of ailments and traumas.

However, it is worth noting that repeated or frequent usage of cortisone injections can damage the tissues and cause unwanted side effects. Enter PRP, or platelet-rich plasma. PRP injections offer a viable alternative to corticosteroid injections, without all of the nasty side effects. Were going to briefly review an exciting medical study that pits the two against each other to measure their effectiveness. Which one will reign supreme? But first, lets define each.

Everybodys blood contains plasma in addition to red and white blood cells. They are important for forming blood clots. Plasma also contains growth factors, which are important for regenerative medicine in helping to regenerate and relieve your condition. By concentrating and reinserting plasma into the affected location of the body, your plasma is being transferred in great quantities to the part of the body its needed the most to jump-start the healing process. The growth factors stimulate cell growth to allow your tissue to repair.

A valuable tool for treating inflammation. This corticosteroid is a synthetic version of a natural hormone called cortisol. Cortisone is used to treat inflammatory conditions, including autoimmune diseases as well as joint swelling and pain. Its natural counterpart, cortisol, is produced by the bodys adrenal glands. This hormone suppresses the immune systems inflammatory and allergic responses. The synthetic derivative cortisone mimics the action of cortisol but tends to achieve a more powerful as well as exposing the patient to potentially greater side effects.

In a 2020 Study by the Journal of Orthopedic Surgery and Research, 40 patients were treated for osteoarthritis. Half of the group were treated utilizing cortisone injections, while the other half had PRP injections. Results were monitored throughout the treatment period, and up to one year after the final injection.

Ultimately, no adverse reactions were noted in either group. However, heres where things get interesting. In the corticosteroids group, pain relief and improvement was observed up until week 15. After week 15, the CS patients actually started regressing with pain creeping up on them once again.

Contrast this with the effects of the PRP group, who observed pain relief for up to 30 weeks following the final injection. Additionally, the PRP group vastly outperformed the Corticosteroids group in several metrics relating to flexibility and pain levels. This study proves the clinical efficacy of PRP and presents it as a superior option over corticosteroids for not only pain relief, but regeneration of the tissues and the restoration of activity levels.

Regenerative Therapy on Better CT

Are you struggling with chronic pains? Have you tried corticosteroid injections with temporary or minimal results? RNP Regenerative Medicine offers better alternatives! Our tailored treatment programs are customized to your needs. We offer PRP injections along with post-injection therapy programs to enhance our patients recoveries as well as their lives. Dr. Roshni Patel has 15 years of experience in treating patients with interventional pain management and regenerative medicine for joint therapy. Call or book an appointment online to learn more about what treatment is right for you.

Continued here:
PRP vs Corticosteroid Injections Which is the Ultimate Solution - Farmington, CT - Patch.com

What is Osteoarthritis and what are the symptoms? – Monitor

By:Dr. Carissa Kirk DHR Health Orthopedic Institute

Osteoarthritis (OA) is the most common degenerative joint disease and a major cause of pain and disability in adult individuals. The etiology of OA includes joint injury, obesity, aging, and heredity. OA signs and symptoms include articular cartilage degradation, osteophyte formation, subchondral sclerosis and synovial hyperplasia, and the signaling pathway(s) controlling these pathological processes that can accelerate the process. Currently, there are no interventions available to restore degraded cartilage or decelerate disease progression.

The knee joint is a hinge type synovial joint that predominately allows for flexion and extension (and a small degree of medial and lateral rotation). Its function is to bear weight, perform physical activity and exhibit a joint-specific range of motion during movement. During OA development, the entire joint organ is affected, including articular cartilage, subchondral bone, synovial tissue and meniscus. Although OA primarily affects the elderly, sports-related traumatic injuries at all ages can lead to post-traumatic OA. Currently, apart from pain management and end stage surgical intervention, there are no effective therapeutic treatments for OA to prevent or halt its progression. The most common risk factor for OA is age. Patients with obesity develop OA earlier and have more severe symptoms, higher risk for infection, and more technical difficulties for total joint replacement surgery. In addition to the increased biomechanical loading on the knee joint, obesity is thought to contribute to low-grade systemic inflammation through secretion of adipose tissue-derived cytokines, called adipokines.

Major clinical symptoms may include: Pain after overuse, after long periods of inactivity, or at the end of the day Stiffness in the morning or after periods of rest Bony enlargements in the middle and end joints of the fingers (which may or may not be painful) Joint swelling Limited range of motion that may go away after movement Clicking or cracking sound when a joint bends Muscle weakness around the joint Joint instability or buckling (knee gives out)

Nonpharmacologic interventions may include: Patient education Heat and cold Weight loss Exercise Physical therapy Occupational therapy Unloading in certain joints (eg, knee, hip)

Pharmacologic interventions may include: Analgesics and anti-inflammatory drugs, Tylenol or NSAIDs Intra-articular injections, which may include a corticosteroid, hyaluronic acid [HA] or hyaluronan) or a biologic agent such as platelet-rich plasma [PRP] Supplements such as glucosamine and chondroitin sulfate

Ultimately when non-invasive treatment options fail to resolve and/or alleviate some of the symptoms associated with OA, invasive procedures may include: Arthroscopy Osteotomy Fusion Arthroplasty

If you or someone you know would like more information on osteoarthritis, please call the DHR Health Orthopedic Institute at (956) 362-6683.

Read the original post:
What is Osteoarthritis and what are the symptoms? - Monitor

Platelet Rich Plasma in Patients with Partial Thickness Rotator Cuff Tears or Tendinopathy Leads to Significantly Improved Short-Term Pain Relief and…

Purpose: The purpose of this study was to perform a randomized controlled trial, comparing platelet-rich plasma (PRP) to standard corticosteroid (CS) in providing pain relief and improved function in patients with rotator cuff tendinopathy and partial thickness rotator cuff tears (PTRCT).

Methods:This double-blind randomized-controlled trial enrolled patients with ultrasound or MRI proven PTRCT to either an ultrasound-guided PRP or CS injection. Patients completed patient reported outcomes at baseline, 6 weeks, 3 and 12 months post-injection. The primary outcome was improvement in visual analog scale for pain (VAS). Secondary outcomes included change in American Shoulder Elbow Surgeons (ASES) and Western Ontario Rotator Cuff index (WORC) scores. Failure of treatment was defined by subsequent injection, consent to surgery or operative intervention.

Results:99 patients (47 in the PRP and 52 in the CS groups) were followed to 12 months post-injection. There were no differences in baseline patient demographics including age, sex or duration of symptoms. Despite randomization, patients in the PRP group had worse baseline VAS (46.0 vs. 34.7, p=0.01), ASES (53.9 vs. 61.8, p=0.02) and WORC (42.2 vs. 49.5, p=0.03) scores. At 3 months post-injection, the PRP group had superior improvement in VAS (-13.6 vs. 0.4, p=0.03), ASES (13.0 vs. 2.9, p=0.02) and WORC (16.8 vs. 5.8, p=0.03) scores. There were no differences in patient reported outcomes at 6 weeks or 12 months. There was no difference in failure rates (p=0.31) or conversion to surgery (p=0.83) between groups.

Conclusions:Patients with PTRCTs or tendinopathy experienced clinical improvement in pain and patient-reported outcome scores after both ultrasound-guided CS and PRP injections. Patients who received PRP obtained superior improvement in pain and function at short-term follow up (3 months). There was no sustained benefit of PRP over CS at longer-term follow-up (12 months).

Level of evidence:Level 1, Randomized controlled trial.

Continued here:
Platelet Rich Plasma in Patients with Partial Thickness Rotator Cuff Tears or Tendinopathy Leads to Significantly Improved Short-Term Pain Relief and...

Platelet Rich Plasma Market Outlook 2020 Scope and Business Growth Overview by Regions, Latest Trends, and Opportunities Forecast to 2024 – The Daily…

Octapharma AG

For More Information or Query or Customization Before Buying, Visit at https://www.industryresearch.co/enquiry/pre-order-enquiry/13999558

Key Market Trends:

Pure PRP Segment by Type is Expected to Hold the Largest Market Share

The pure PRP segment of the global platelet rich plasma market is believed to have the largest market share.

The prime factor responsible for the growth of this segment is the significance of this type of platelet plasma for the person. Pure PRP has an edge over traditional PRP, as it requires a two-step concentration process that helps in eliminating unwanted red blood cells (RBCs) and neutrophils. RBCs (that have no therapeutic effects for regeneration) can create a more viscous solution that can be more painful when injected. Neutrophils, a type of white blood cell, have inflammatory components that may increase pain and inflammation post-treatment.

Pure PRP helps the stem cells and regenerative cells in the repair and in rebuilding the damaged tissue. This ultimately speeds up the healing process and reduces pain. In addition, it promotes increased strength and improves the overall function. Therefore, owing to the contribution of pure PRP in the healing process and the rising use of it as a blood product, the segment is expected to dominate the market in the coming future.

North America Dominates the Market and is Expected to Continue the Same Trend for Next Few Years

North America currently dominates the platelet-rich plasma market and is expected to continue its stronghold for a few more years. The United States is a major market, and this is mainly due to the US governments initiatives to develop blood products. In addition, the emergence and adoption of novel technologies are going to help the market in a positive manner.

Competitive Landscape:

Most of the companies present in the market are efficient at the technological front, but require significant support for enhancing their services and expanding their businesses. Thus, mergers and acquisitions offer significant opportunities to gain the attention of a large number of providers across developed regions.

Purchase this Report (Price 4250 USD for single user license) https://www.industryresearch.co/purchase/13999558

Platelet Rich Plasma Market Covers Following Points in TOC:

1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS 4.1 Market Overview 4.2 Market Drivers 4.2.1 Rising Incidences of Sports Injuries 4.2.2 Increasing Number of Androgenic Alopecia Patients 4.2.3 Growing Use of Platelet-rich Plasma in Various Therapeutic Areas 4.2.4 Rising Prevalence of Arthritis 4.3 Market Restraints 4.3.1 Stringent Regulatory Policies 4.3.2 High Prices of Plasma Therapy 4.4 Porters Five Forces Analysis 4.4.1 Threat of New Entrants 4.4.2 Bargaining Power of Buyers/Consumers 4.4.3 Bargaining Power of Suppliers 4.4.4 Threat of Substitute Products 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION 5.1 By Type 5.1.1 Pure PRP 5.1.2 Leukocyte-rich PRP 5.1.3 Pure Platelet-rich Fibrin 5.1.4 Leukocyte-rich Fibrin 5.2 By Source 5.2.1 Autologous 5.2.2 Allogenic 5.3 By Application 5.3.1 Orthopedic 5.3.1.1 Arthritis 5.3.1.2 Chronic Tendinitis 5.3.1.3 Bone Repair and Regeneration 5.3.2 Dermatology 5.3.2.1 Androgenic Alopecia 5.3.2.2 Plastic Surgery 5.3.2.3 Cardiac Muscle Injury 5.3.2.4 Dental 5.3.2.5 Nerve Injury 5.3.2.6 Other Applications 5.3.3 By End User 5.3.3.1 Hospitals and Clinics 5.3.3.2 Research Institutes 5.3.3.3 Other End Users 5.4 Geography 5.4.1 North America 5.4.1.1 United States 5.4.1.2 Canada 5.4.1.3 Mexico 5.4.2 Europe 5.4.2.1 Germany 5.4.2.2 United Kingdom 5.4.2.3 France 5.4.2.4 Italy 5.4.2.5 Spain 5.4.2.6 Rest of Europe 5.4.3 Asia-Pacific 5.4.3.1 China 5.4.3.2 Japan 5.4.3.3 India 5.4.3.4 Australia 5.4.3.5 South Korea 5.4.3.6 Rest of Asia-Pacific 5.4.4 Middle East & Africa 5.4.4.1 GCC 5.4.4.2 South Africa 5.4.4.3 Rest of Middle East & Africa 5.4.5 South America 5.4.5.1 Brazil 5.4.5.2 Argentina 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 Bio Product Laboratory Ltd (BPL) 6.1.2 Biolife Plasma Services 6.1.3 Biotest AG 6.1.4 Cambryn Biologics LLC 6.1.5 China Biologic Products Inc. 6.1.6 CSL Ltd 6.1.7 Grifols International SA 6.1.8 Kedrion SpA 6.1.9 LFB SA 6.1.10 Octapharma AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Wearable Inertial Sensors Market Size, Share Forecast 2020 | Growth Insights, Business Trends by Types and Applications, Opportunities and Challenges Forecast to 2025

Monofilament Evaluator Market Business Growth Rate, Top Key Players with COVID-19 Outbreak, Regional Overview, Upcoming Trends, Industry Size & Share Forecast to 2026

Resorcinol Formaldehyde Latex Market by Growth Size Analysis 2020 | Future Trends by Regions, Prominent Players, Global Developments Status, Industry Segments with Business Share Forecast to 2026

Lighting as a Service (LaaS) Market Size, Share Forecast 2020 | Growth Insights, Business Trends by Types and Applications, Opportunities and Challenges Forecast to 2025

Artificial Neural Networks Market Growth Factors by Latest Developments 2020 | Future Demand Status, Business Strategies, Opportunities, Trends, Industry Size and Share Forecast to 2026

Waste Paper Recycling Market Size 2020 | Global Trends Analysis by Growth Demand, Key Players by Share Analysis Forecast to 2025 Report by Industry Research.co

Telco Digital AI Assistants & Chatbots Market Size 2020 | Global Manufacturers with Forthcoming Developments, Regional Overview, Growth Analysis by Key Findings, Demand Status Forecast to 2025

Spunmelt Nonwoven Fabrics Market Share and Size Analysis 2020 Global Industry Segments by Regions, Types and Applications, Future Demand Status, Growth Dynamics with COVID-19 Impact till 2026

Ultra High Purity Boron Market Share, Growth Analysis 2020 Industry Size with Regional Segmentations, Business Challenges and Opportunities Forecast to 2024

LED Face Masks Market Business Growth Rate, Top Key Players with COVID-19 Outbreak, Regional Overview, Upcoming Trends, Industry Size & Share Forecast to 2026

Gas Industrial Tumble Dryer Market Growth Share and Development Analysis 2020 | Global Driving Factors by Manufacturers, CAGR Status with Size, Latest Challenges and Opportunities Forecast to 2026

3D Imaging in 5G Smartphone Market Growth Share and Development Analysis 2020 | Global Driving Factors by Manufacturers, CAGR Status with Size, Latest Challenges and Opportunities Forecast to 2026

Link:
Platelet Rich Plasma Market Outlook 2020 Scope and Business Growth Overview by Regions, Latest Trends, and Opportunities Forecast to 2024 - The Daily...

Platelet-rich Plasma Market To Witness the Highest Growth Globally in Coming Years 2020-2025 – The Daily Philadelphian

The Platelet-rich Plasma Market Research Report 2020 to 2025 presents an in-depth assessment of the Station Platelet-rich Plasma It provides the industry overview with market growth analysis with a historical & futuristic perspective considering the following parameters; cost, revenue, demands, and supply data (as applicable). The bottom-up approach was used to estimate the global market size of Station Platelet-rich Plasma based on end-use applications in the various regions, in terms of USD million. The report covers the historic growth of the market, the impact of the COVID-19, and also forecasts its recovery post-COVID-19. The report also presents forecasts for Platelet-rich Plasma investments from 2020 to 2025.

Top Companies in the Global Platelet-rich Plasma Market:Arthrex, Inc., Cambryn Biologics LLC, China Biologic Products Inc., DePuy Synthes, Dr. PRP USA LLC, EmCyte Corporation, Glofinn Oy, T-Biotechnology, Terumo BCT, Inc., and Zimmer Biomet

The platelet-rich plasma (PRP) market is expected to register a CAGR of approximately 14.2%, over the forecast period.

Market OverviewThe key factors that are augmenting the growth of the market include rising incidences of sports injuries, an increasing number of cosmetic and surgical procedures, and growing use of platelet-rich plasma in various therapeutic areas. PRP contains at least seven growth factors, and it can be used for various treatments, such as chronic tendon injuries, acute ligament, and muscle injuries, surgery, knee arthritis, fractures, and pain. In orthopedics, the use of PRP is expected to increase over the period. PRP is increasingly being used in the treatment of acute sports injuries, such as muscle injuries. The popularity of PRP is on the rise, but its true effectiveness is yet to be fully established. The PRP is thus widely used in surgery to repair torn knee ligaments, such as the anterior cruciate ligament (ACL). The PRP facilitates the fast healing of the tissue after surgical procedures. Several research studies are currently being conducted to evaluate the effectiveness of PRP in other treatment areas, such as in the case of herniated disc and hair loss. The use of PRP has grown widely in different therapeutic areas, owing to the increasing availability and ability to enable faster healing.

Get a Sample PDF Copy of the Latest Research on Platelet-rich Plasma Market 2020 Before the purchase https://www.marketinsightsreports.com/reports/10192354530/platelet-rich-plasma-market-growth-trends-and-forecasts-2020-2025/inquiry?Mode=46

Market InsightsThe Orthopedics Segment by Application is Expected to Hold the Largest Market Share According to the US Arthritis Foundation, arthritis is the leading cause of disability among adults in the country. By conservative estimates, about 54 million adults were diagnosed with arthritis and almost 300,000 children were suffering from arthritis or rheumatic condition (2017-2018). Despite not being considered the standard practice, a growing number of people are opting for PRP injections, to treat an expanding list of orthopedic conditions, including osteoarthritis. It is most commonly used for knee osteoarthritis but may be used on other joints as well. While treating osteoarthritis with platelet-rich plasma, a doctor injects PRP directly into the affected joint, in order to reduce pain, improve joint function, and slow, halt, or even repair damage to the cartilage. In such cases, platelet-rich plasma is derived from a sample of the patients own blood. Platelet-rich plasma therapy is thus witnessing a significant rise in its popularity and acceptance, for treating arthritis, owing to the fact that it inhibits inflammation, reduces the rate of progression of osteoarthritis, stimulates the formation of new cartilage, and increases the production of natural lubricating joint fluid, thus, easing painful joint friction, and it also contains proteins that alter a patients pain receptors and reduces pain sensation. Hence, the aforementioned factors are expected to fuel the growth of the arthritis segment.

North America Dominates the Market and is Expected to Depict Similar Trend Over the Forecast Period The market growth in the country can be attributed to several factors, including the rise in the prevalence of several disorders, such as arthritis, well-established healthcare infrastructure, better regulatory framework, and government support. As per a survey conducted by the Centers for Disease Control and Prevention (CDC), in the United States, in 2018, about 54.4 million adults (22.7%) were diagnosed with common arthritis, rheumatoid arthritis, and gout. Moreover, in the country, due to the growing aging population, the prevalence of doctor-diagnosed arthritis is expected to rise significantly, over the forecast period. Osteoarthritis is the most prevalent type of arthritis, and it affects about 31 million Americans every year.

Regions Are covered By Platelet-rich Plasma Market Report 2020 To 2025.

North America, Europe, China, Japan, Southeast Asia, India. North America (USA, Canada, and Mexico). Europe (Germany, France, UK, Russia, and Italy). Asia-Pacific (China, Japan, Korea, India, and Southeast Asia).

The report has 150 tables and figures browse the report description and TOChttps://www.marketinsightsreports.com/reports/10192354530/platelet-rich-plasma-market-growth-trends-and-forecasts-2020-2025?Mode=46

Significant Features that are under Offering and Key Highlights of the Reports:

-Detailed overview of Platelet-rich Plasma Market -Changing the Platelet-rich Plasma market dynamics of the industry -In-depth market segmentation by Type, Application, etc. -Historical, current and projected Platelet-rich Plasma market size in terms of volume and value Recent industry trends and developments -Competitive landscape of Platelet-rich Plasma Market -Strategies of key players and product offerings -Potential and niche segments/regions exhibiting promising growth.

Frequently Asked Questions about Platelet-rich Plasma market:

What are the recent developments and government policies? Why might we forecast a downturn in a particular economy next year? Why do we say the currency is set to appreciate? What countries and sectors offer the highest potential? Where are the greatest dangers?

We Also Offer Customization on report based on specific client Requirementcountry Level analysis for any 5 countries of your choice. Competitive analysis of any 5 key market players. 40 analyst hours to cover any other data point.

All the reports that we list have been tracking the impact of COVID-19 on the market. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

ABOUT US

Market Insights Reports is an online market research reports library of 500,000 in-depth studies of over 5000 micro markets. Market Insights Reports offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food, and beverages, water, advanced materials, and much more.

Contact Us

Irfan Tamboli Market Insights Reports Phone: + 1704 266 3234 | +91-750-707-8687[emailprotected] | [emailprotected]

Read more:
Platelet-rich Plasma Market To Witness the Highest Growth Globally in Coming Years 2020-2025 - The Daily Philadelphian

Wrist Pain: Causes and Available Treatment Options – Lifesly.com

Hands are an essential part of the body as they perform numerous tasks daily. You may assume that your hands will always be fine. While going about your daily activities, you may experience wrist pain, which can be traumatizing. Wrist pain can deter you from performing your daily tasks. Your Jersey City hand and wrist pain specialists at Garden State Pain Control offer specialized treatment procedures for hand and wrist pain.

You can experience pain in the hand and wrist due to:

Inappropriate use

Overworking

Severe injury

System-wide disorders

You may sprain or fracture your hands if you misuse them or carry massive weights that your hands cannot handle. You may also accidentally hurt your hands during sporting activities or an accidental slip to the ground. When you hurt your hands, you are likely to experience a strain due to stretching or tearing of tendons. On the other hand, sprains come about when ligaments receive aggressive stretches or bends to the extent of causing pain. Fractures occur when the pressure acting on your bones is irresistible, resulting in breaks and excruciating pain. Systemic disorders like osteoarthritis and rheumatoid arthritis can also lead to pain in the wrist. Further, prolonged use of the hands leads to wrist and hand pains.

Carpal tunnel syndrome arises due to a nerve compression resulting in a tingling sensation and is usually experienced when you use your hand often. Signs of carpal tunnel syndrome include a tingling sensation, loss of sensation, or pain in your fingers, usually the thumb, index, and middle fingers. You are likely to feel uneasiness in your wrist or the whole arm. Additional symptoms are:

Persistent pain after doing a task

Inability to firmly hold on to tiny items

Severe hand and wrist pain at night

The professional team at Garden State Pain Control uses ultrasound to examine your ligaments, structural bones, joints, and other parts. This procedure involves using a handheld probe that disperses sound waves in high frequency, bouncing off your bones, ligaments, and tendons. The computer collects these sound waves and employs them to produce a clear image of the pain points.

The doctors at Garden State Pain Control have specialized in pain medicine, making them able to examine your wrist problems and administer the correct treatment. Holding on to chronic hand and wrist pain can lead to long-term damage. The treatment procedure for persistent hand and wrist pain include:

Taking pain relievers

Alternating hands when handling a task

Relaxing your hand

Your physicians also provide platelet-rich plasma injections that help in soothing the pain. Injecting PRP promotes the production of soft tissue and bones, which enhances faster healing.

It is essential to take care of your hands as they handle many tasks daily. It would help if you did not ignore hand and wrist pain. Reach out to your Garden State Pain Control doctor to learn how to keep your hands free from pain.

The post Wrist Pain: Causes and Available Treatment Options appeared first on Living Gossip.

Link:
Wrist Pain: Causes and Available Treatment Options - Lifesly.com

Platelet Rich Plasma Market Analysis 2020 Growth Prospects and Future Scenario of Industry Size and Share and Market Insights Forecast to 2024 -…

The rising prevalence of the arthritis is augmenting the demand of the blood products, which is ultimately helping the growth of the platelet-rich plasma market.

Inquire or Share Your Questions If Any Before the Purchasing This Report https://www.industryresearch.co/enquiry/pre-order-enquiry/13999558

Key Market Trends:

Pure PRP Segment by Type is Expected to Hold the Largest Market Share

The pure PRP segment of the global platelet rich plasma market is believed to have the largest market share.

The prime factor responsible for the growth of this segment is the significance of this type of platelet plasma for the person. Pure PRP has an edge over traditional PRP, as it requires a two-step concentration process that helps in eliminating unwanted red blood cells (RBCs) and neutrophils. RBCs (that have no therapeutic effects for regeneration) can create a more viscous solution that can be more painful when injected. Neutrophils, a type of white blood cell, have inflammatory components that may increase pain and inflammation post-treatment.

Pure PRP helps the stem cells and regenerative cells in the repair and in rebuilding the damaged tissue. This ultimately speeds up the healing process and reduces pain. In addition, it promotes increased strength and improves the overall function. Therefore, owing to the contribution of pure PRP in the healing process and the rising use of it as a blood product, the segment is expected to dominate the market in the coming future.

North America Dominates the Market and is Expected to Continue the Same Trend for Next Few Years

North America currently dominates the platelet-rich plasma market and is expected to continue its stronghold for a few more years. The United States is a major market, and this is mainly due to the US governments initiatives to develop blood products. In addition, the emergence and adoption of novel technologies are going to help the market in a positive manner.

Reason to buy Platelet Rich Plasma Market Report:

Purchase this Report (Price 4250 USD for a Single-User License) https://www.industryresearch.co/purchase/13999558

Detailed TOC of Platelet Rich Plasma Market 2020-2024:

1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS 4.1 Market Overview 4.2 Market Drivers 4.2.1 Rising Incidences of Sports Injuries 4.2.2 Increasing Number of Androgenic Alopecia Patients 4.2.3 Growing Use of Platelet-rich Plasma in Various Therapeutic Areas 4.2.4 Rising Prevalence of Arthritis 4.3 Market Restraints 4.3.1 Stringent Regulatory Policies 4.3.2 High Prices of Plasma Therapy 4.4 Porters Five Forces Analysis 4.4.1 Threat of New Entrants 4.4.2 Bargaining Power of Buyers/Consumers 4.4.3 Bargaining Power of Suppliers 4.4.4 Threat of Substitute Products 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION 5.1 By Type 5.1.1 Pure PRP 5.1.2 Leukocyte-rich PRP 5.1.3 Pure Platelet-rich Fibrin 5.1.4 Leukocyte-rich Fibrin 5.2 By Source 5.2.1 Autologous 5.2.2 Allogenic 5.3 By Application 5.3.1 Orthopedic 5.3.1.1 Arthritis 5.3.1.2 Chronic Tendinitis 5.3.1.3 Bone Repair and Regeneration 5.3.2 Dermatology 5.3.2.1 Androgenic Alopecia 5.3.2.2 Plastic Surgery 5.3.2.3 Cardiac Muscle Injury 5.3.2.4 Dental 5.3.2.5 Nerve Injury 5.3.2.6 Other Applications 5.3.3 By End User 5.3.3.1 Hospitals and Clinics 5.3.3.2 Research Institutes 5.3.3.3 Other End Users 5.4 Geography 5.4.1 North America 5.4.1.1 United States 5.4.1.2 Canada 5.4.1.3 Mexico 5.4.2 Europe 5.4.2.1 Germany 5.4.2.2 United Kingdom 5.4.2.3 France 5.4.2.4 Italy 5.4.2.5 Spain 5.4.2.6 Rest of Europe 5.4.3 Asia-Pacific 5.4.3.1 China 5.4.3.2 Japan 5.4.3.3 India 5.4.3.4 Australia 5.4.3.5 South Korea 5.4.3.6 Rest of Asia-Pacific 5.4.4 Middle East & Africa 5.4.4.1 GCC 5.4.4.2 South Africa 5.4.4.3 Rest of Middle East & Africa 5.4.5 South America 5.4.5.1 Brazil 5.4.5.2 Argentina 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 Bio Product Laboratory Ltd (BPL) 6.1.2 Biolife Plasma Services 6.1.3 Biotest AG 6.1.4 Cambryn Biologics LLC 6.1.5 China Biologic Products Inc. 6.1.6 CSL Ltd 6.1.7 Grifols International SA 6.1.8 Kedrion SpA 6.1.9 LFB SA 6.1.10 Octapharma AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Passive Fire Protection Coatings Market Size Analysis and Growth Outlook 2020 | Global Industry Share, Top Companies with Revenue, Topmost Opportunities, Industry Dynamics till 2026

Hi-Performance Stretch Film Market Size by Growth Scenario 2020 Trend Analysis, Industry Status by Manufacturers, Business Share, Future Scope and Global Opportunities Forecast to 2026

Glycerin Fatty Acid Ester Market Size by Impressive Growth Rate 2020 Business Size, Global Share, Industry Overview by Future Plans, Top Key Players Forecast to 2026 | Report by Industry Research.co

Portable Ultrasonic Flowmeter Market Size by Future Scope 2020 | Global Industry Revenue, Share, Future Demand Status, Growth Segmentations Analysis by Regions Forecast to 2026

Electrophysiology Devices Market Size by Future Scope 2020 | Global Industry Revenue, Share, Future Demand Status, Growth Segmentations Analysis by Regions Forecast to 2026

Cloud Collaboration Market 2020 by Top Countries Data with Share Analysis, Global Growth Trends, Market Size by Top Players, Geographical Segmentation Forecast to 2024

Blower Market Size by Future Demand Status, Global Industry Revenue of Top Key Players, Industry Share and Manufacturing Cost | COVID-19 Impact Forecast by 2020-2026

Furaldehyde Market Share and Size Analysis 2020 by Regional Demand Status, Future Growth Rate, Manufacturers, Trends by Market Dynamics and Development Scope till 2026

Ethoxylated Sorbitan Ester Market Size, Global Growth Rate Forecast by Regions 2020 | Future Trends with Key Manufacturers, Development Status till 2024

PVB Film Market Future Trends, Growth Factors 2020: Global Opportunities by Leading Countries, Manufacturing Size and Share, Industry Segments by Types and Applications Forecast to 2026

Flow Meters Market Size, Share and CAGR Status 2020 Global Industry Data by Top Manufacturers, Business Boosting Strategies, Upcoming Trends, Emerging Growth Factors till 2026

Read the original:
Platelet Rich Plasma Market Analysis 2020 Growth Prospects and Future Scenario of Industry Size and Share and Market Insights Forecast to 2024 -...

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Trend, Growth, COVID-19 Impact, Current Industry Figures and Forecast 2026 -…

LOS ANGELES, United States: QY Research has recently published a research report titled, Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size, Status and Forecast 2020-2026. This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.

The report includes CAGR, market shares, sales, gross margin, value, volume, and other vital market figures that give an exact picture of the growth of the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.

Key questions answered in the report:

TOC

1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Market Analysis by Type 1.3.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size Growth Rate by Type: 2020 VS 2026 1.3.2 Platelet Rich Plasma Injections 1.3.3 Stem Cell Therapy 1.4 Market by Application 1.4.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Share by Application: 2020 VS 2026 1.4.2 Dermatology Clinics 1.4.3 Hospitals 1.5 Study Objectives 1.6 Years Considered

2 Global Growth Trends 2.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Perspective (2015-2026) 2.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Growth Trends by Regions 2.2.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Historic Market Share by Regions (2015-2020) 2.2.3 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Forecasted Market Size by Regions (2021-2026) 2.3 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Industry Dynamic 2.3.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Trends 2.3.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Drivers 2.3.3 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Challenges 2.3.4 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Restraints

3 Competition Landscape by Key Players 3.1 Global Top Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Players by Market Size 3.1.1 Global Top Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Players by Revenue (2015-2020) 3.1.2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue Market Share by Players (2015-2020) 3.2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue 3.4 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Concentration Ratio 3.4.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue in 2019 3.5 Key Players Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Area Served 3.6 Key Players Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Product Solution and Service 3.7 Date of Enter into Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market 3.8 Mergers & Acquisitions, Expansion Plans

4 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Breakdown Data by Type 4.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Historic Market Size by Type (2015-2020) 4.2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Forecasted Market Size by Type (2021-2026)

5 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Breakdown Data by Application 5.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Historic Market Size by Application (2015-2020) 5.2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Forecasted Market Size by Application (2021-2026)

6 North America 6.1 North America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2026) 6.2 North America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020) 6.3 North America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020) 6.4 North America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada

7 Europe 7.1 Europe Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2026) 7.2 Europe Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020) 7.3 Europe Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020) 7.4 Europe Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic

8 Asia-Pacific 8.1 Asia-Pacific Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2026) 8.2 Asia-Pacific Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020) 8.3 Asia-Pacific Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020) 8.4 Asia-Pacific Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia

9 Latin America 9.1 Latin America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2026) 9.2 Latin America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020) 9.3 Latin America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020) 9.4 Latin America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil

10 Middle East & Africa 10.1 Middle East & Africa Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2026) 10.2 Middle East & Africa Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020) 10.3 Middle East & Africa Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020) 10.4 Middle East & Africa Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE

11 Key Players Profiles 11.1 Orange County Hair Restoration Center 11.1.1 Orange County Hair Restoration Center Company Details 11.1.2 Orange County Hair Restoration Center Business Overview 11.1.3 Orange County Hair Restoration Center Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction 11.1.4 Orange County Hair Restoration Center Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020)) 11.1.5 Orange County Hair Restoration Center Recent Development 11.2 Hair Sciences Center of Colorado 11.2.1 Hair Sciences Center of Colorado Company Details 11.2.2 Hair Sciences Center of Colorado Business Overview 11.2.3 Hair Sciences Center of Colorado Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction 11.2.4 Hair Sciences Center of Colorado Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020) 11.2.5 Hair Sciences Center of Colorado Recent Development 11.3 Anderson Center for Hair 11.3.1 Anderson Center for Hair Company Details 11.3.2 Anderson Center for Hair Business Overview 11.3.3 Anderson Center for Hair Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction 11.3.4 Anderson Center for Hair Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020) 11.3.5 Anderson Center for Hair Recent Development 11.4 Evolution Hair Loss Institute 11.4.1 Evolution Hair Loss Institute Company Details 11.4.2 Evolution Hair Loss Institute Business Overview 11.4.3 Evolution Hair Loss Institute Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction 11.4.4 Evolution Hair Loss Institute Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020) 11.4.5 Evolution Hair Loss Institute Recent Development 11.5 Savola Aesthetic Dermatology Center 11.5.1 Savola Aesthetic Dermatology Center Company Details 11.5.2 Savola Aesthetic Dermatology Center Business Overview 11.5.3 Savola Aesthetic Dermatology Center Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction 11.5.4 Savola Aesthetic Dermatology Center Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020) 11.5.5 Savola Aesthetic Dermatology Center Recent Development 11.6 Virginia Surgical Center 11.6.1 Virginia Surgical Center Company Details 11.6.2 Virginia Surgical Center Business Overview 11.6.3 Virginia Surgical Center Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction 11.6.4 Virginia Surgical Center Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020) 11.6.5 Virginia Surgical Center Recent Development 11.7 Hair Transplant Institute of Miami 11.7.1 Hair Transplant Institute of Miami Company Details 11.7.2 Hair Transplant Institute of Miami Business Overview 11.7.3 Hair Transplant Institute of Miami Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction 11.7.4 Hair Transplant Institute of Miami Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020) 11.7.5 Hair Transplant Institute of Miami Recent Development 11.8 Colorado Surgical Center & Hair Institute 11.8.1 Colorado Surgical Center & Hair Institute Company Details 11.8.2 Colorado Surgical Center & Hair Institute Business Overview 11.8.3 Colorado Surgical Center & Hair Institute Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction 11.8.4 Colorado Surgical Center & Hair Institute Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020) 11.8.5 Colorado Surgical Center & Hair Institute Recent Development

12 Analysts Viewpoints/Conclusions

13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

See the rest here:
Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Trend, Growth, COVID-19 Impact, Current Industry Figures and Forecast 2026 -...